Fidelity Investments
WHWK

Fidelity Investments’s Whitehawk Therapeutics WHWK Stock Holding History

Fidelity Investments’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$779 Buy
+170
New +$707 ﹤0.01% 5267
2024
Q4 		– Sell
-2,600
Closed -$5.36K – 5868
2024
Q3 		$5.36K Sell
2,600
-14,344
-85% -$23.2K ﹤0.01% 4616
2024
Q2 		$24.7K Buy
16,944
+12,935
+323% +$24K ﹤0.01% 3969
2024
Q1 		$9.38K Buy
4,009
+1,467
+58% +$2.83K ﹤0.01% 4301
2023
Q4 		$5.13K Buy
2,542
+323
+15% +$1.35K ﹤0.01% 4443
2023
Q3 		$10.7K Buy
2,219
+1,416
+176% +$8.23K ﹤0.01% 4090
2023
Q2 		$5.49K Sell
803
-3,321
-81% -$25.8K ﹤0.01% 4338
2023
Q1 		$29.9K Buy
4,124
+3,852
+1,416% +$41.2K ﹤0.01% 3661
2022
Q4 		$3.49K Sell
272
-2,224
-89% -$29K ﹤0.01% 4364
2022
Q3 		$35K Buy
2,496
+2,437
+4,131% +$32K ﹤0.01% 3618
2022
Q2 		$1K Buy
+59
New +$876 ﹤0.01% 4825
2018
Q4 		– Sell
-37,700
Closed -$1.75M – 4254
2018
Q3 		$1.75M Sell
37,700
-20,907
-36% -$1.17M ﹤0.01% 2393
2018
Q2 		$3.65M Buy
+58,607
New +$3.54M ﹤0.01% 2223

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments's WHWK Position: Q2 2026 in Review

Fidelity Investments opened a new position in Whitehawk Therapeutics (WHWK) in Q2 2026: 170 shares worth $779. The stake represents ﹤0.01% of the portfolio and ranks #5267 among its holdings. This is a return to the name: Fidelity Investments previously reported a position in WHWK as recently as Q3 2024.

Fidelity Investments first reported a position in WHWK in Q2 2018 and has held it in 13 quarters since. The position peaked at $3.65M in Q2 2018. 78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Fidelity Investments held 170 shares of Whitehawk Therapeutics worth $779 as of Q2 2026.
  • Whitehawk Therapeutics was a new Fidelity Investments position in Q2 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #5267 holding.
  • Fidelity Investments first reported a position in Whitehawk Therapeutics in Q2 2018 and has held it in 13 quarters since.
  • Fidelity Investments's Whitehawk Therapeutics position peaked at $3.65M in Q2 2018.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.